Compare TKLF & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKLF | EVGN |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | Japan | Israel |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4M | 9.6M |
| IPO Year | 2020 | 2013 |
| Metric | TKLF | EVGN |
|---|---|---|
| Price | $2.25 | $0.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | 7.3K | ★ 41.9K |
| Earning Date | 12-19-2025 | 05-20-2026 |
| Dividend Yield | ★ 10.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $73.33 |
| P/E Ratio | $2.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.95 | $0.72 |
| 52 Week High | $4.32 | $2.42 |
| Indicator | TKLF | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 39.31 |
| Support Level | $2.06 | $0.73 |
| Resistance Level | $2.38 | $0.86 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 28.09 | 16.00 |
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.